DeepMed Research

SANOFI PASTEUR

🇫🇷France

Country: 🇫🇷France

Ownership: Subsidiary

Established: 1990-01-01

Employees: 10K

Market Cap: -

Website: http://www.sanofipasteur.com

Clinical Trials

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

Phase 1

Recruiting

Conditions: Acne

Interventions: Other: Placebo
Biological: Acne mRNA vaccine

First Posted Date: 2024-03-18

Last Posted Date: 2025-05-15

Lead Sponsor: Sanofi Pasteur, a Sanofi Company

Target Recruit Count: 260

Registration Number: NCT06316297

Locations: 🇺🇸
Center for Clinical Studies, LTD. LLP- Site Number : 8400002, Houston, Texas, United States
🇺🇸
Louisiana Dermatology Associates LLC, DelRicht Research at LA Dermatology Associates Site Number : 8400043, Baton Rouge, Louisiana, United States
🇺🇸
DelRicht Research Site Number : 8400013, New Orleans, Louisiana, United States

and more 9 locations

Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers

Phase 3

Active, not recruiting

Conditions: Meningococcal Immunisation
Healthy Volunteers

Interventions: Biological: MenACYW conjugate vaccine

First Posted Date: 2024-02-29

Last Posted Date: 2025-03-07

Lead Sponsor: Sanofi Pasteur, a Sanofi Company

Target Recruit Count: 840

Registration Number: NCT06284915

Locations: 🇨🇿
Investigational Site Number : 2030002, Ceske Budejovice, Czechia
🇵🇱
Investigational Site Number : 6160001, Bydgoszcz, Kujawsko-pomorskie, Poland
🇷🇴
Investigational Site Number : 6420001, Bucuresti, Romania

and more 42 locations

Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Phase 3

Active, not recruiting

Conditions: RSV Immunisation

Interventions: Biological: RSVt Vaccine
Biological: Placebo

First Posted Date: 2024-02-09

Last Posted Date: 2025-01-14

Lead Sponsor: Sanofi Pasteur, a Sanofi Company

Target Recruit Count: 6300

Registration Number: NCT06252285

Locations: 🇺🇸
National Institute of Clinical Research - Victorville - ClinEdge - PPDS- Site Number : 8400040, Victorville, California, United States
🇺🇸
Parkside Pediatrics - Simpsonville- Site Number : 8400071, Simpsonville, South Carolina, United States
🇺🇸
Private Practice - Dr. Chinyere N. Awa- Site Number : 8400066, Houston, Texas, United States

and more 127 locations

Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and Older

Phase 2

Completed

Conditions: Respiratory Syncytial Virus Infection
Healthy Volunteers

Interventions: Biological: Placebo
Biological: RSV vaccine candidate

First Posted Date: 2024-02-09

Last Posted Date: 2025-04-04

Lead Sponsor: Sanofi Pasteur, a Sanofi Company

Target Recruit Count: 4541

Registration Number: NCT06251024

Locations: 🇲🇽
Investigational Site Number : 4840002, Leon, Guanajuato, Mexico
🇨🇴
Investigational Site Number : 1700001, Quindio, Colombia
🇩🇴
Investigational Site Number : 2140001, Santo Domingo, Dominican Republic

and more 22 locations

Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older

Phase 1

Completed

Conditions: Healthy Volunteers
Respiratory Syncytial Virus Infection
Metapneumovirus Infection

Interventions: Biological: RSV/hMPV mRNA LNP 1
Biological: RSV/hMPV mRNA LNP 2
Biological: RSV mRNA LNP 1
Biological: hMPV mRNA LNP 1

First Posted Date: 2024-02-01

Last Posted Date: 2025-02-27

Lead Sponsor: Sanofi Pasteur, a Sanofi Company

Target Recruit Count: 558

Registration Number: NCT06237296

Locations: 🇺🇸
Velocity Clinical Research-Hallandale Beach- Site Number : 8400013, Hallandale Beach, Florida, United States
🇺🇸
Advanced Clinical Research- Site Number : 8400005, Meridian, Idaho, United States
🇺🇸
Meridian Clinical Research- Site Number : 8400007, Binghamton, New York, United States

and more 14 locations

Study on a MenACYW Conjugate Vaccine Administered as a Single Dose in Participants Aged 12 Months and Older in Vietnam

Phase 3

Completed

Conditions: Meningococcal Infection
Healthy Volunteers

Interventions: Biological: Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine

First Posted Date: 2024-01-29

Last Posted Date: 2025-04-09

Lead Sponsor: Sanofi Pasteur, a Sanofi Company

Target Recruit Count: 446

Registration Number: NCT06228586

Locations: 🇻🇳
Investigational Site Number : 7040004, Thai Binh, Vietnam
🇻🇳
Investigational Site Number : 7040001, Hanoi, Vietnam
🇻🇳
Investigational Site Number : 7040002, Thai Binh City, Vietnam

and more 1 locations

A Phase I, Randomized, Modified Single-blind, Active-controlled (Infants Only), Four-stage, Step-down, Comparative, Multi-center Study

Phase 1

Completed

Conditions: Meningococcal Immunization

Interventions: Biological: Meningococcal (Groups A, C, Y and W-135) Polysaccharide Tetanus Protein Conjugate Vaccine (TetraMen-T).
Biological: Meningococcal Group C-CRM197 Conjugate Vaccine

First Posted Date: 2023-12-11

Last Posted Date: 2023-12-11

Lead Sponsor: Sanofi Pasteur, a Sanofi Company

Target Recruit Count: 285

Registration Number: NCT06165276

Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate

Phase 1

Active, not recruiting

Conditions: Healthy Volunteers
Respiratory Syncytial Virus Infection
Human Metapneumovirus

Interventions: Biological: RSV/hMPV vaccine candidate Dose L
Biological: RSV/hMPV vaccine candidate Dose B
Biological: Placebo
Biological: RSV/hMPV vaccine candidate Dose A

First Posted Date: 2023-11-18

Last Posted Date: 2024-08-14

Lead Sponsor: Sanofi Pasteur, a Sanofi Company

Target Recruit Count: 646

Registration Number: NCT06134648

Locations: 🇺🇸
Velocity Clinical Research, Sioux City Site Number : 8400012, Sioux City, Iowa, United States
🇺🇸
AMR Lexington Site Number : 8400008, Lexington, Kentucky, United States
🇵🇷
Investigational Site Number : 6300001, San Juan, Puerto Rico

and more 10 locations

Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents

Phase 1

Active, not recruiting

Conditions: Meningococcal Immunisation
Healthy Volunteers

Interventions: Biological: Pentavalent Meningococcal ABCYW vaccine
Biological: Meningococcal group B vaccine
Biological: MenABCYW conjugate vaccine
Biological: Placebo
Biological: MenACYW conjugate vaccine

First Posted Date: 2023-11-13

Last Posted Date: 2025-01-13

Lead Sponsor: Sanofi Pasteur, a Sanofi Company

Target Recruit Count: 1220

Registration Number: NCT06128733

Locations: 🇺🇸
Accel Research Site - Birmingham Clinical Research Unit- Site Number : 8400080, Birmingham, Alabama, United States
🇺🇸
Alliance for Multispecialty Research- Phoenix- Site Number : 8400056, Tempe, Arizona, United States
🇺🇸
Hope Clinical Research, LLC- Site Number : 8400001, Canoga Park, California, United States

and more 44 locations

Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants 18 Years of Age and Older

Phase 1

Completed

Conditions: Influenza
Influenza Immunization

Interventions: Biological: Influenza Hemagglutinin mRNA vaccine
Biological: Quadrivalent Recombinant Influenza Vaccine

First Posted Date: 2023-11-07

Last Posted Date: 2023-11-07

Lead Sponsor: Sanofi Pasteur, a Sanofi Company

Target Recruit Count: 388

Registration Number: NCT06118151

Locations: 🇺🇸
AMR El Dorado Site Number : 8400009, El Dorado, Kansas, United States
🇺🇸
AMR - Newton Site Number : 8400005, Newton, Kansas, United States
🇺🇸
AMR Wichita West Site Number : 8400030, Wichita, Kansas, United States

and more 17 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy